Cost-Utility Analysis of Noninvasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver Disease
Using FIB-4/VCTE to initiate HCC surveillance is cost-effective for patients with MASLD. If VCTE is unavailable, FIB-4 alone is a cost-effective alternative for MASLD patients with diabetes or 3 metabolic traits.
Authors
- Sombat Treeprasertsuk (ORCID: https://orcid.org/0000-0001-6459-8329)
- Roongruedee Chaiteerakij (ORCID: https://orcid.org/0000-0002-7191-3881)
- Phunchai Charatcharoenwitthaya (ORCID: https://orcid.org/0000-0002-8334-0267)
- Thoetchai Peeraphatdit (ORCID: https://orcid.org/0000-0001-7254-5016)
- Suthira Taychakhoonavudh (ORCID: https://orcid.org/0000-0002-0620-0762)
- Pakanat Decharatanachart (ORCID: https://orcid.org/0000-0002-8460-9563)
- Kittiyod Poovorawan (ORCID: https://orcid.org/0000-0001-7016-7605)
- Pisit Tangkijvanich (ORCID: https://orcid.org/0000-0002-2926-8671)
Institutions
- Thai Red Cross Society (TH)
- Siriraj Hospital (TH)
- Chulalongkorn University (TH)
- Mahidol University (TH)
- King Chulalongkorn Memorial Hospital (TH)
- Mahidol Oxford Tropical Medicine Research Unit (TH)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2025-01-29
- DOI
- https://doi.org/10.14309/ajg.0000000000003332
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.06